Dimitri Muganis's guest appearances

Dimitri Muganis

Psychedelics Today

Tom Shroder

Ryan Zurrer

Michael Pollan

Richard Grossman

David Krantz

Becca Segall Tarnas

Renn Butler

Joe Moore

Adam Strauss

Lynn Marie Morski

Rick Doblin

Harvey Schwartz

Daniel Pinchbeck

Dennis McKenna

Zach Leary

OwlTail

In this episode Kyle and Joe speak about the recent interview they recorded with  Dimitri Muganis. There were some relatively important points in the interview that needed further discussion and expansion and in this podcast we unravel some of the material. There is plenty more to unpack there. Some of what is discussed in this episode includes.  Race Class Research and Treatment  When should one take priority   Democratization of the medicines Privilege Paying for people to participate in research The white upper middle class bias in the research The bias in research towards veterans  Overall there are loads of things that we discussed, and in short the real message here is that we all need to keep moving forward. There is plenty of room for growth in the field for all of us to move our agendas forward. With endless amounts of research left to be run, we can still treat people. I'm not sure we are going to see Psychedelic medicines be used in the next 1-2 years in major hospitals outside of research, but we are going to see it in the next decade for sure. Lets keep moving and taking care of each other. -Joe Sign up for our mailing list here.

In this episode Kyle and Joe speak about the recent interview they recorded with <a href="http://www.psychedelicstoday.com/2016/09/16/dimitri-mugianis-iboga-psychedelic-gas-lighting-and-structural-criticism/" rel="nofollow" target="_blank"> Dimitri Mugani</a>s. There were some relatively important points in the interview that needed further discussion and expansion and in this podcast we unravel some of the material. There is plenty more to unpack there. Some of what is discussed in this episode includes. <ul> <li>Race</li> <li>Class</li> <li>Research and Treatment <ul> <li>When should one take priority</li> </ul> </li> <li>Democratization of the medicines</li> <li>Privilege</li> <li>Paying for people to participate in research</li> <li>The white upper middle class bias in the research</li> <li>The bias in research towards veterans</li> </ul> Overall there are loads of things that we discussed, and in short the real message here is that we all need to keep moving forward. There is plenty of room for growth in the field for all of us to move our agendas forward. With endless amounts of research left to be run, we can still treat people. I'm not sure we are going to see Psychedelic medicines be used in the next 1-2 years in major hospitals outside of research, but we are going to see it in the next decade for sure. Lets keep moving and taking care of each other. -Joe Sign up for our mailing list <a href="http://www.psychedelicstoday.com/mailing-list/" rel="nofollow" target="_blank">here</a>.

Kyle and Joe Talking About The Interview with Dimitri Muganis and the Field